litlas
ログインアカウント作成

Peter A. Kaufman

1978–2024 年に発表

67
論文数
18,064
被引用数
48
h 指数
66
i10 指数

被引用数

Peter A. Kaufman の年別被引用数1974 年: 被引用 1 件1981 年: 被引用 3 件1982 年: 被引用 1 件1987 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 1 件1993 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 10 件1998 年: 被引用 5 件1999 年: 被引用 5 件2000 年: 被引用 10 件2001 年: 被引用 6 件2002 年: 被引用 5 件2003 年: 被引用 6 件2004 年: 被引用 4 件2005 年: 被引用 17 件2006 年: 被引用 81 件2007 年: 被引用 126 件2008 年: 被引用 152 件2009 年: 被引用 147 件2010 年: 被引用 156 件2011 年: 被引用 167 件2012 年: 被引用 167 件2013 年: 被引用 172 件2014 年: 被引用 168 件2015 年: 被引用 168 件2016 年: 被引用 144 件2017 年: 被引用 137 件2018 年: 被引用 158 件2019 年: 被引用 412 件2020 年: 被引用 576 件2021 年: 被引用 514 件2022 年: 被引用 446 件2023 年: 被引用 374 件2024 年: 被引用 513 件2025 年: 被引用 281 件2026 年: 被引用 11 件1975〜1980 年は被引用が無いため表示していません1983〜1986 年は被引用が無いため表示していません1988〜1990 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,150 件、この内訳の 26.6%中国: 引用元論文 572 件、この内訳の 7.1%イタリア: 引用元論文 504 件、この内訳の 6.2%イギリス: 引用元論文 458 件、この内訳の 5.7%ドイツ: 引用元論文 424 件、この内訳の 5.3%カナダ: 引用元論文 328 件、この内訳の 4.1%フランス: 引用元論文 319 件、この内訳の 3.9%スペイン: 引用元論文 306 件、この内訳の 3.8%日本: 引用元論文 224 件、この内訳の 2.8%ベルギー: 引用元論文 214 件、この内訳の 2.6%韓国: 引用元論文 208 件、この内訳の 2.6%オーストラリア: 引用元論文 207 件、この内訳の 2.6%
0%26.6%その他 26.7%

機関

分野

  • Medicine68.1%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Engineering3.5%
  • Business, Management and Accounting3.3%
  • Computer Science1.5%
  • Immunology and Microbiology1.4%
  • その他4.5%

トピック

  • HER2/EGFR in Cancer Research11.7%
  • Advanced Breast Cancer Therapies9.4%
  • Breast Cancer Treatment Studies7.7%
  • Cancer Treatment and Pharmacology4%
  • Monoclonal and Polyclonal Antibodies Research3.3%
  • Cancer-related Molecular Pathways3.2%
  • その他60.7%

共著者

全論文

検索で開く
  1. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

    著者: George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva‐Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. P. Smith, Nawel Bourayou, Antonio Llombart‐Cussac - Journal of Clinical Oncology 2017 被引用: 1,656

  2. The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

    著者: George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva‐Maria Grischke, PierFranco Conte, Yi Lu, Susana Barriga, Karla Hurt, Martin Frenzel, Stephen Johnston, Antonio Llombart‐Cussac - JAMA Oncology 2019 被引用: 987

  3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    著者: Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark - New England Journal of Medicine 2005 被引用: 5,353

  4. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

    著者: Nadia Harbeck, Priya Rastogi, Miguel Martín, Sara M. Tolaney, Zhimin Shao, Peter A. Fasching, Chiun‐Sheng Huang, Georgina Garnica Jaliffe, A. Tryakin, Matthew P. Goetz, Hope S. Rugo, Elżbieta Senkus, Laura Testa, Mariette Andersson, Kenji Tamura, Lucia Del Mastro, Guenther G. Steger, Hans Kreipe, Roberto Hegg, Joohyuk Sohn, Valentina Guarneri, Javier Cortés, E.P. Hamilton, Valérie André, Ran Wei, Susana Barriga, S. Sherwood, Tammy Forrester, Montserrat Muñoz-Mateu, Ashwin Shahir, Belén San Antonio, Sarah C. Nabinger, Masakazu Toi, Stephen Johnston, Joyce O’Shaughnessy, M.M. Jimenez, Stephen Johnston, F. Boyle, Guenther G. Steger, Patrick Neven, Zefei Jiang, Mario Campone, Jens Huober, Chikako Shimizu, I. Cicin, Andrew Wardley, Sara M. Tolaney, Gonzalo Gómez Abuin, J. J. Zarba, Elgene Lim, P. Sant, Naishun Liao, Bo Christiansen, Natalja Eigėlienė, J. Martin-Babau, Johannes Ettl, D. Mavroudis, Joanne Chiu, Katalin Boér, R. Nagarkar, Shani Paluch–Shimon, Luca Moscetti, Yoshiatsu Sagara, S.-B. Kim, Rui M. B. Maciel, Vivianne C. G. Tjan‐Heijnen, Reuben Broom, Aleksandra Łacko, M. Schenker, Nikita Volkov, Yoon Sim Yap, M.A. Coccia-Portugal, J. Ángel García Sáenz, Anne Andersson, Tai-Jong Chao, Erhan Gökmen, Hakan Harputluoğlu, O. Berzoy, Debra A. Patt, Heather L. McArthur, Helen K. Chew, Pavani Chalasani, Peter A. Kaufman, Karen L. Tedesco, Stephanie L. Graff - Annals of Oncology 2021 被引用: 378

  5. Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

    著者: Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso, Javier Cortés, Giuseppe Curigliano, Antonino Musolino, Mark D. Pegram, Thomas Bachelot, Gail S. Wright, Cristina Saura, Santiago Escrivá-de-Romaní, Michelino De Laurentiis, Gary N. Schwartz, Timothy Pluard, Francesco Ricci, William R. Gwin, Christelle Lévy, Ursa Brown‐Glaberman, Jean-­Marc Ferrero, Maaike de Boer, Sung‐Bae Kim, Katarína Petráková, Denise A. Yardley, Orit Freedman, Erik Jakobsen, Einav Nili Gal‐Yam, Rinat Yerushalmi, Peter A. Fasching, Peter A. Kaufman, Emily J. Ashley, Raul Perez-Olle, Shengyan Hong, Minori Koshiji Rosales, William J. Gradishar, on behalf of the SOPHIA Study Group - Journal of Clinical Oncology 2022 被引用: 80

  6. AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

    著者: Sara M. Tolaney, Arlene Chan, Katarína Petráková, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F. Peddi, Peter A. Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, Seock‐Ah Im - Journal of Clinical Oncology 2023 被引用: 74

  7. E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group

    著者: Roisín M. Connolly, Fengmin Zhao, Kathy D. Miller, Min-Jung Lee, Richard Piekarz, Karen L. Smith, Ursa Brown‐Glaberman, Jennifer S. Winn, Bryan A. Faller, Adedayo A. Onitilo, Mark E. Burkard, G. Thomas Budd, Ellis Levine, Melanie Royce, Peter A. Kaufman, Alexandra Thomas, Jane B. Trepel, Antonio C. Wolff, Joseph A. Sparano - Journal of Clinical Oncology 2021 被引用: 119

  8. Abemaciclib plus fulvestrant vs fulvestrant alone for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy: Primary outcome of the phase 3 postMONARCH trial.

    著者: Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L. Graff, Kyong Hwa Park, Rinath Jeselsohn, Umut Demırcı, Miguel Martín, Rachel M. Layman, Sara A. Hurvitz, Sarah Sammons, Peter A. Kaufman, Montserrat Muñoz-Mateu, Ling‐Ming Tseng, Holly Knoderer, Bastien Nguyen, Yanhong Zhou, Elizabeth E. Ravenberg, Lacey M. Litchfield, Seth A. Wander - Journal of Clinical Oncology 2024 被引用: 75

  9. Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

    著者: Sara M. Tolaney, Kevin Kalinsky, Virginia Kaklamani, David R. D’Adamo, Gursel Aktan, Michaela L. Tsai, Ruth O’Regan, Peter A. Kaufman, Sharon Wilks, Eleni Andreopoulou, Debra A. Patt, Yuan Yuan, Grace Wang, Claudio Savulsky, Dongyuan Xing, Ella Kleynerman, Vassiliki Karantza, Sami Diab - Clinical Cancer Research 2021 被引用: 136

  10. Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

    著者: Sònia Pernas, Miguel Martín, Peter A. Kaufman, Marta Gil-Martín, P. Gómez Pardo, Sara López‐Tarruella, Luís Manso, Eva Ciruelos, José Alejandro Pérez Fidalgo, Cristina Hernándo, Foluso O. Ademuyiwa, Katherine N. Weilbaecher, Ingrid A. Mayer, Timothy Pluard, Maria Martinez‐García, Linda T. Vahdat, José Manuel Pérez-García, Achim Wach, Debra Barker, Samson Fung, Bárbara Romagnoli, Javier Cortés - The Lancet Oncology 2018 被引用: 137

  11. Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer

    著者: Matthew P. Goetz, Erika Hamilton, Mario Campone, Sara A. Hurvitz, Javier Cortés, Stephen Johnston, Antonio Llombart‐Cussac, Peter A. Kaufman, Masakazu Toi, Guy Jérusalem, Hillary Graham, Hong Wang, Valerie M. Jansen, Lacey M. Litchfield, Miguel Martín - Clinical Cancer Research 2023 被引用: 41

  12. Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

    著者: Peter A. Kaufman, Ahmad Awada, Chris Twelves, Louise Yelle, Edith A. Perez, Galina Velikova, Martin Olivo, Yi He, Corina E. Dutcus, Javier Cortés - Journal of Clinical Oncology 2015 被引用: 464

  13. Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

    著者: Adam Brufsky, Musa Mayer, Hope S. Rugo, Peter A. Kaufman, Elizabeth Tan-Chiu, Debu Tripathy, Iulia Cristina Tudor, Lisa I. Wang, Melissa Brammer, Mona Shing, Marianne Ulcickas Yood, Denise A. Yardley - Clinical Cancer Research 2011 被引用: 400

  14. Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study

    著者: Komal Jhaveri, Elgene Lim, Rinath Jeselsohn, X. Cynthia, Erika Hamilton, Cynthia R. Osborne, Manali Ajay Bhave, Peter A. Kaufman, J. Thaddeus Beck, Luís Manso, Ritesh Parajuli, Hwei-Chung Wang, Jessica J. Tao, Seock‐Ah Im, Kathleen Harnden, Kan Yonemori, Ajay Dhakal, Patrick Neven, Philippe Aftimos, Jean‐Yves Pierga, Yen‐Shen Lu, Timothy Larson, Yolanda Jerez, Kostandinos Sideras, Joohyuk Sohn, Sung‐Bae Kim, Cristina Saura, Aditya Bardia, Sarah Sammons, Francesca Bacchion, Yujia Li, Eunice Yuen, Shawn T. Estrem, Vanessa Rodrik-Outmezguine, Bastien Nguyen, Roohi Ismail‐Khan, Lillian M. Smyth, Muralidhar Beeram - Journal of Clinical Oncology 2024 被引用: 38

  15. Enhancing global access to cancer medicines

    著者: Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac, Giuseppe Curigliano, Nagi S. El Saghir, Fátima Cardoso, Carlos H. Barrios, S. M. S. Wagle, Javier Pareja Román, Nadia Harbeck, Alexandru Eniu, Peter A. Kaufman, Josep Tabernero, Laura García‐Estévez, Peter Schmid, Joaquı́n Arribas - CA A Cancer Journal for Clinicians 2020 被引用: 205

  16. Fast 3-D Tomographic Microwave Imaging for Breast Cancer Detection

    著者: Tomasz M. Grzegorczyk, Paul M. Meaney, Peter A. Kaufman, Roberta M. di Florio-Alexander, Keith D. Paulsen - IEEE Transactions on Medical Imaging, IEEE Trans. Medical Imaging 2012 被引用: 339

  17. Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

    著者: Sara A. Hurvitz, Joyce O’Shaughnessy, Ginny Mason, Denise A. Yardley, Mohammad Jahanzeb, Adam Brufsky, Hope S. Rugo, Sandra M. Swain, Peter A. Kaufman, Debu Tripathy, Laura Chu, Haocheng Li, Vincent Antao, Melody Cobleigh - Clinical Cancer Research 2018 被引用: 114

  18. De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

    著者: Debu Tripathy, Adam Brufsky, Melody Cobleigh, Mohammad Jahanzeb, Peter A. Kaufman, Ginny Mason, Joyce O’Shaughnessy, Hope S. Rugo, Sandra M. Swain, Denise A. Yardley, Laura Chu, Haocheng Li, Vincent Antao, Sara A. Hurvitz - The Oncologist 2019 被引用: 68

  19. Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve

    著者: Tim A. Ahles, Andrew J. Saykin, Brenna C. McDonald, Yuelin Li, Charlotte T. Furstenberg, Brett Hanscom, Tamsin J. Mulrooney, Gary N. Schwartz, Peter A. Kaufman - Journal of Clinical Oncology 2010 被引用: 534

  20. Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial

    著者: Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L. Graff, Kyong Hwa Park, Rinath Jeselsohn, Umut Demirci, Miguel Martín, Rachel M. Layman, Sara A. Hurvitz, Sarah Sammons, Peter A. Kaufman, Montserrat Muñoz-Mateu, Jiun‐I Lai, Holly Knoderer, Cynthia Sandoval, Aarti Chawla, Bastien Nguyen, Yanhong Zhou, Elizabeth E. Ravenberg, Lacey M. Litchfield, Lillian M. Smyth, Seth A. Wander - Journal of Clinical Oncology 2024 被引用: 63

  21. A phase 1a/b trial of imlunestrant (LY3484356), an oral selective estrogen receptor degrader (SERD) in ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC): Monotherapy results from EMBER.

    著者: Komal Jhaveri, Rinath Jeselsohn, Elgene Lim, Erika Hamilton, Kan Yonemori, J. Thaddeus Beck, Peter A. Kaufman, Sarah Sammons, Manali Bhave, Cristina Saura, Emiliano Calvo, Tarek Meniawy, Timothy Larson, X. Cynthia, Javier García-Corbacho, Shanshan Cao, Shawn T. Estrem, Jennifer L. Milata, Bastien Nguyen, Muralidhar Beeram - Journal of Clinical Oncology 2022 被引用: 39

  22. Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

    著者: Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, Nancy E. Davidson, Charles E. Geyer, Silvana Martino, Eleftherios P. Mamounas, Peter A. Kaufman, Norman Wolmark - Journal of Clinical Oncology 2011 被引用: 718

  23. Cognitive function in breast cancer patients prior to adjuvant treatment

    著者: Tim A. Ahles, Andrew J. Saykin, Brenna C. McDonald, Charlotte T. Furstenberg, Bernard F. Cole, Brett Hanscom, Tamsin J. Mulrooney, Gary N. Schwartz, Peter A. Kaufman - Breast Cancer Research and Treatment 2007 被引用: 346

  24. Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy

    著者: Peter A. Kaufman, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Eva‐Maria Grischke, Valérie André, C. Stoffregen, Sarah Shekarriz, Gregory L. Price, Gebra Cuyún Carter, George W. Sledge - The Oncologist 2019 被引用: 83